LakeShore Biopharma Co., Ltd. - LSBCF
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | History | Added to | 4,298,465 | 5,931 | 0.11% | 0.14% | 1 | +1 | 0.0% | Q2 2023 | Aug 14, 2023 |
| FIL Ltd | History | No change | 2,718,499 | 3,751 | 0.0% | 0.0% | 2 | 0 | 0.0% | Q2 2023 | Aug 11, 2023 |
| FMR LLC | History | No change | 1,165,071 | 1,607 | 0.0% | 0.0% | 3 | 0 | 0.0% | Q2 2023 | Aug 11, 2023 |
| BARCLAYS PLC | History | New | 108,894 | 150 | 0.0% | — | 4 | +108,894 | New | Q2 2023 | Mar 30, 2026 |
| XTX Topco Ltd | History | New | 22,514 | 31 | 0.01% | — | 5 | +22,514 | New | Q2 2023 | Aug 14, 2023 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | History | New | 15,262 | 21 | 0.0% | — | 6 | +15,262 | New | Q2 2023 | Aug 11, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | History | No change | 13,608 | 18 | 0.0% | 0.0% | 7 | 0 | 0.0% | Q2 2023 | Aug 11, 2023 |
| UBS Group AG | History | New | 7,049 | 9 | 0.0% | — | 8 | +7,049 | New | Q2 2023 | Aug 11, 2023 |
| RTW INVESTMENTS, LP | History | Closed out | 0 | 0 | — | 0.01% | — | -341,090 | -100.0% | Q2 2023 | Aug 14, 2023 |
| MILLENNIUM MANAGEMENT LLC | History | Closed out | 0 | 0 | — | 0.0% | — | -23,086 | -100.0% | Q2 2023 | Aug 14, 2023 |
| JANE STREET GROUP, LLC | History | Closed out | 0 | 0 | — | 0.0% | — | -11,971 | -100.0% | Q2 2023 | Aug 14, 2023 |
| WOLVERINE ASSET MANAGEMENT LLC | History | No change | 499 | 0 | — | — | — | 0 | 0.0% | Q2 2023 | Aug 07, 2023 |